Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 2 2Phase 3 1Phase 2/3 1Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Adenomatous Polyposis Coli 2Wounds and Injuries 1Surgical Wound Infection 1Surgical Wound 1Eyelid Diseases 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Erythromycin × Clear all
NCT03199911 2020-07-21

Topical Antibiotic Prophylaxis for Eyelids

University of California, San Francisco

Phase 4 Completed
401 enrolled 28 charts

Surgical Wound, Eyelid Diseases, Surgical Wound Infection, Wounds and Injuries

NCT02354560 2015-02-03

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
15 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT02175914 2014-06-26

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
20 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡